Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
GRDN
Guardian Pharmacy Services
GRDN
Market cap
$1.58B
Overview
Fund Trends
Analyst Outlook
Journalist POV
24.95
USD
+0.58
2.38%
At close
Updated
Oct 17, 4:00 PM EDT
Pre-market
After hours
24.95
0.00
0%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
2.38%
5 days
5.68%
1 month
-8.17%
3 months
19.89%
6 months
3.48%
Year to date
25.44%
1 year
43.56%
5 years
55.94%
10 years
55.94%
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
77.8%
Negative
Positive
Neutral
Negative
Neutral
Business Wire
3 days ago
Guardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common Stock
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) (“Guardian”), one of the nation's leading long-term care (LTC) pharmacy services companies, today announced that it has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC). The registration statement relates to (i) the possible issuance and sale of up to 1,020,000 shares of Class A common stock by Guardian and (ii) the potential resale of up to 4,980,000 outstanding shares.
Neutral
Business Wire
11 days ago
Guardian Pharmacy Services, Inc. to Report Third Quarter 2025 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) announced today that it will release its third quarter 2025 results on Monday, November 10th, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participa.
Neutral
Seeking Alpha
15 days ago
Guardian Pharmacy Services, Inc. (GRDN) Presents at Jefferies 2025 Healthcare Services Conference Transcript
Guardian Pharmacy Services, Inc. (NYSE:GRDN ) Jefferies 2025 Healthcare Services Conference September 30, 2025 4:35 PM EDT Company Participants Fred Burke - CEO, President & Director Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Presentation Brian Tanquilut Jefferies LLC, Research Division Good afternoon, and we're here for our last presentation of the day, but saving the best for last, right? So we have a Guardian Pharmacy Services as our next presenter.
Neutral
Business Wire
1 month ago
Guardian Pharmacy Services, Inc. to Participate in Upcoming Jefferies Healthcare Services Investor Conference
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Jefferies Healthcare Services Conference in Nashville, TN, on Tuesday, September 30, 2025. The company will host investor meetings, and Fred Burke, Co-founder and Chief Executive Officer, will take part in a fireside chat with Jefferies analyst, Brian Tanquilut, at 3:35 p.m. CT (4:35 p.m. ET) the same day. A live audio webcast of the session will be available at https://invest.
Positive
Zacks Investment Research
1 month ago
Guardian Pharmacy Services (GRDN)'s Technical Outlook is Bright After Key Golden Cross
Guardian Pharmacy Services, Inc. (GRDN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, GRDN's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Positive
Zacks Investment Research
1 month ago
Guardian Pharmacy (GRDN) Upgraded to Buy: What Does It Mean for the Stock?
Guardian Pharmacy (GRDN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Neutral
Business Wire
2 months ago
Guardian Pharmacy Services Reports Second Quarter 2025 Financial Results; Raises Full-Year Guidance
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the second quarter ended June 30, 2025. Second Quarter Financial Results Revenue of $344.3 million, up 15% year-over-year, driven by low double-digit organic growth and acquisitions completed over the past 12 months. Resident count ended the quarter over 195,000, up 12% year-over-year. Net Income of $8.
Neutral
Business Wire
2 months ago
Guardian Pharmacy Services Strengthens Pacific Northwest Presence with Acquisition of Oregon-based Managed Healthcare Pharmacy
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Managed Healthcare Pharmacy, a leading long-term care pharmacy in Oregon.
Neutral
Business Wire
2 months ago
Guardian Pharmacy Services, Inc. to Report Second Quarter 2025 Financial Results and Host Conference Call
ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) announced today that it will release its second quarter 2025 results on Monday, August 11, 2025, after market close and host a conference call to review the results at 4:30 pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (646) 564-2877 for U.S. participants, or +1 (800) 549-8228 for international participants.
Neutral
Business Wire
4 months ago
Guardian Pharmacy of South Carolina Opens New Headquarters in Charleston to Support Statewide Growth
CHARLESTON, S.C.--(BUSINESS WIRE)--Winyah Pharmacy and Preferred Care rebrand as Guardian Pharmacy of South Carolina, and open new high-tech Charleston headquarters.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close